Product Wiki · Recalls · U.S. FDA — Device Enforcement

Recall Z-1925-2017 — Magellan Diagnostics LeadCare Ultra Blood Analyzer Part Number: 80-0010

U.S. FDA — Device Enforcement · United States · 2014-11-29 · Class I

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →
Agency
U.S. FDA — Device Enforcement
Recall identifier
Z-1925-2017
Date of alert
2014-11-29
Country / jurisdiction
United States
Risk level
Class I
Risk type
recall
Brand
Magellan Diagnostics, Inc.
Product category
device
Product type
Devices
Reported risk: LeadCare Plus and LeadCare Ultra Blood Lead Testing Systems may generate falsely low lead concentrations in some blood samples. The issue is observed when blood samples are collected in tubes with lavender and tan rubber stoppers of the Becton Dickinson EDTA Vacutainer tubes, a collection device used with the testing system.
Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.